In summary, HDAC6 is expressed at elevated levels in CLD, and on the basis of these studies using two novel selective small molecule inhibitors, it is worthy of further mechanistic and pharmacological investigation as a profibrogenic protein deacetylase in the context of liver damage but also in other fibrosing conditions. Here, HDAC6 is linked to congenital secretory chloride diarrhea 1.